PEComa
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers (NCT03190174) | Sarcoma Oncology Research Center, LLC | 2017-08-24 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors (NCT02334930) | University Hospital, Bordeaux | 2015-04-01 |
| Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery (NCT02180867) | National Cancer Institute (NCI) | 2014-08-12 |
Track PEComa automatically
Every clearance here is in the API, with alerts when new ones post.